Literature DB >> 6338232

Chemotherapy and the adult gonad: a review.

J Waxman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6338232      PMCID： PMC1438671          DOI： 10.1177/014107688307600212

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  37 in total

1.  Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist.

Authors:  C Bergquist; S J Nillius; L Wide
Journal:  Contraception       Date:  1979-05       Impact factor: 3.375

2.  Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?

Authors:  S J Nillius; C Bergquist; L Wide
Journal:  Contraception       Date:  1978-06       Impact factor: 3.375

3.  Plasma oestradiol and progesterone levels in women with varying degrees of risk of breast cancer.

Authors:  R D Bulbrook; J W Moore; G M Clark; D Y Wang; D Tong; J L Hayward
Journal:  Eur J Cancer       Date:  1978-12       Impact factor: 9.162

4.  Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function.

Authors:  R M Chapman; S B Sutcliffe; J S Malpas
Journal:  JAMA       Date:  1979-10-26       Impact factor: 56.272

5.  Unusual anti-reproductive properties of the analog [d-Leu6,des-Gly-NH2(10)]-luteinizing hormone-releasing hormone ethylamide in male rats.

Authors:  R K Tcholakian; A de la Cruz; M Chowdhury; A Steinberger; D H Coy; A V Schally
Journal:  Fertil Steril       Date:  1978-11       Impact factor: 7.329

6.  1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers.

Authors:  B Fisher; B Sherman; H Rockette; C Redmond; R Margolese; E R Fisher
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

7.  Cyclical combination chemotherapy and gonadal function. Retrospective study in males.

Authors:  R M Chapman; S B Sutcliffe; L H Rees; C R Edwards; J S Malpas
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

8.  Testicular damage due to cytotoxic drugs and recovery after cessation of therapy.

Authors:  H P Roeser; A E Stocks; A J Smith
Journal:  Aust N Z J Med       Date:  1978-06

9.  Carcinogenic and other adverse effects of procarbazine in nonhuman primates.

Authors:  S M Sieber; P Correa; D W Dalgard; R H Adamson
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

10.  Morphological study of the ovaries of leukaemic children.

Authors:  R Himelstein-Braw; H Peters; M Faber
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640
View more
  10 in total

Review 1.  Impact of environmental exposures on ovarian function and role of xenobiotic metabolism during ovotoxicity.

Authors:  Poulomi Bhattacharya; Aileen F Keating
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-13       Impact factor: 4.219

2.  Fertility following treatment of high-grade malignant bone and soft tissue tumors in young adults.

Authors:  Manabu Hoshi; Masatsugu Takami; Makoto Ieguchi; Masanari Aono; Jun Takada; Naoto Oebisu; Tadashi Iwai; Hiroaki Nakamura
Journal:  Mol Clin Oncol       Date:  2014-12-03

Review 3.  Oncofertility and the male cancer patient.

Authors:  Landon W Trost; Robert E Brannigan
Journal:  Curr Treat Options Oncol       Date:  2012-06

Review 4.  Ovarian Stem Cells (OSCs) from the Cryopreserved Ovarian Cortex: A Potential for Neo-Oogenesis in Women with Cancer-Treatment Related Infertility: A Case Report and a Review of Literature.

Authors:  Erica Silvestris; Carla Minoia; Attilio Guarini; Giuseppina Opinto; Antonio Negri; Miriam Dellino; Raffaele Tinelli; Gennaro Cormio; Angelo Virgilio Paradiso; Giuseppe De Palma
Journal:  Curr Issues Mol Biol       Date:  2022-05-19       Impact factor: 2.976

Review 5.  Maintaining the reproductive potential of cancer patients during cancer treatment.

Authors:  Djana Harp; Indrajit Chowdhury; Minerva Garcia-Barrio; Crystal Welch; Roland Matthews; Winston Thompson
Journal:  Front Biosci (Schol Ed)       Date:  2014-01-01

6.  Anti-inflammatory and immunosuppressive drugs and reproduction.

Authors:  Monika Østensen; Munther Khamashta; Michael Lockshin; Ann Parke; Antonio Brucato; Howard Carp; Andrea Doria; Raj Rai; Pierluigi Meroni; Irene Cetin; Ronald Derksen; Ware Branch; Mario Motta; Caroline Gordon; Guillermo Ruiz-Irastorza; Arsenio Spinillo; Deborah Friedman; Rolando Cimaz; Andrew Czeizel; Jean Charles Piette; Ricard Cervera; Roger A Levy; Maurizio Clementi; Sara De Carolis; Michelle Petri; Yehuda Shoenfeld; David Faden; Guido Valesini; Angela Tincani
Journal:  Arthritis Res Ther       Date:  2006-05-11       Impact factor: 5.156

7.  Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure.

Authors:  Dongmei Lai; Fangyuan Wang; Xiaofen Yao; Qiuwan Zhang; Xiaoxing Wu; Charlie Xiang
Journal:  J Transl Med       Date:  2015-05-12       Impact factor: 5.531

Review 8.  Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.

Authors:  Hoon Jang; Kwonho Hong; Youngsok Choi
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

Review 9.  Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution In Vitro and Ovarian Regeneration In Vivo.

Authors:  Taichi Akahori; Dori C Woods; Jonathan L Tilly
Journal:  Clin Med Insights Reprod Health       Date:  2019-05-23

10.  Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression.

Authors:  Juan Feng; Wen-Wen Ma; Hui-Xia Li; Xiu-Ying Pei; Shou-Long Deng; Hua Jia; Wen-Zhi Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-03       Impact factor: 6.055
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.